These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 37350298)

  • 1. Trajectory of COVID-19 vaccine hesitancy post-vaccination and public's intention to take booster vaccines: A cross-sectional analysis.
    Salman M; Mallhi TH; Khan YH; Mustafa ZU; Khan MT; Khan FU; Butt MH; Shehzadi N; Farrukh MJ; Waheed M; Azmat F; Saeed A; Mazhar SA; Ali A; Ashfaq A; Hussain K
    Hum Vaccin Immunother; 2023 Aug; 19(2):2225990. PubMed ID: 37350298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Reported COVID-19 Vaccine and Booster Acceptance and Hesitancy Among Autistic Adults in Pennsylvania: Cross-Sectional Analysis of Survey Data.
    Shea L; Cooper D; Ventimiglia J; Frisbie S; Carlton C; Song W; Salzer M; Lee B; Hotez E; Vanness DJ
    JMIR Public Health Surveill; 2024 Aug; 10():e51054. PubMed ID: 39196609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, Usability, and Acceptability of a Chatbot for Promoting COVID-19 Vaccination in Unvaccinated or Booster-Hesitant Young Adults: Pre-Post Pilot Study.
    Luk TT; Lui JHT; Wang MP
    J Med Internet Res; 2022 Oct; 24(10):e39063. PubMed ID: 36179132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia.
    Wong LP; Alias H; Siaw YL; Muslimin M; Lai LL; Lin Y; Hu Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2078634. PubMed ID: 35648441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccine hesitancy among Israeli adults before and after vaccines' availability: A cross-sectional national survey.
    Frankenthal D; Zatlawi M; Karni-Efrati Z; Keinan-Boker L; Luxenburg O; Bromberg M
    Vaccine; 2022 Oct; 40(43):6271-6276. PubMed ID: 36137905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional survey.
    Noh Y; Kim JH; Yoon D; Choe YJ; Choe SA; Jung J; Lee SW; Shin JY
    Epidemiol Health; 2022; 44():e2022061. PubMed ID: 35914771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with COVID-19 booster vaccine hesitancy: a nationwide, cross-sectional survey in Japan.
    Takamatsu A; Honda H; Miwa T; Tabuchi T; Taniguchi K; Shibuya K; Tokuda Y
    Public Health; 2023 Oct; 223():72-79. PubMed ID: 37619504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccination intention and hesitancy: Mistrust on COVID-19 vaccine benefit a major driver for vaccine hesitancy among healthcare workers; a cross-sectional study in North India.
    Jose S; Cyriac MC; Dhandapani M; Joseph J
    J Prev Med Hyg; 2022 Jun; 63(2):E219-E230. PubMed ID: 35968070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study.
    Machida M; Kikuchi H; Kojima T; Nakamura I; Saito R; Nakaya T; Hanibuchi T; Takamiya T; Odagiri Y; Fukushima N; Amagasa S; Watanabe H; Inoue S
    Hum Vaccin Immunother; 2022 Nov; 18(5):2086773. PubMed ID: 35708308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic Trends and Underlying Factors of COVID-19 Vaccine Booster Hesitancy in Adults: Cross-Sectional Observational Study.
    Wu J; Ma M; Li Q; Guo X; Tarimo CS; Jia S; Zhou X; Wang M; Gu J; Miao Y; Ye B
    JMIR Public Health Surveill; 2023 Aug; 9():e44822. PubMed ID: 37526963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding COVID-19 vaccine hesitancy in Pakistan: The paradigm of confidence, convenience, and complacency; A cross-sectional study.
    Sheikh NS; Touseef M; Sultan R; Cheema KH; Cheema SS; Sarwar A; Siddique HZ
    PLoS One; 2023; 18(8):e0289678. PubMed ID: 37585457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries.
    Wong LP; Alias H; Danaee M; Ahmed J; Lachyan A; Cai CZ; Lin Y; Hu Z; Tan SY; Lu Y; Cai G; Nguyen DK; Seheli FN; Alhammadi F; Madhale MD; Atapattu M; Quazi-Bodhanya T; Mohajer S; Zimet GD; Zhao Q
    Infect Dis Poverty; 2021 Oct; 10(1):122. PubMed ID: 34620243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
    AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
    J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in intention and hesitancy regarding COVID-19 vaccines in a cohort of adults in Quebec during the pandemic.
    Dionne M; Rochette L; Hamel D; Dube È
    Hum Vaccin Immunother; 2024 Dec; 20(1):2309006. PubMed ID: 38347660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The psychological and behavioural correlates of COVID-19 vaccine hesitancy and resistance in Ireland and the UK.
    Walsh JC; Comar M; Folan J; Williams S; Kola-Palmer S
    Acta Psychol (Amst); 2022 May; 225():103550. PubMed ID: 35259642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptance rate and risk perception towards the COVID-19 vaccine in Botswana.
    Tlale LB; Gabaitiri L; Totolo LK; Smith G; Puswane-Katse O; Ramonna E; Mothowaeng B; Tlhakanelo J; Masupe T; Rankgoane-Pono G; Irige J; Mafa F; Kolane S
    PLoS One; 2022; 17(2):e0263375. PubMed ID: 35120163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of second COVID-19 booster dose or new COVID-19 vaccine hesitancy among nurses: A cross-sectional study.
    Galanis P; Vraka I; Katsiroumpa A; Siskou O; Konstantakopoulou O; Katsoulas T; Mariolis-Sapsakos T; Kaitelidou D
    J Clin Nurs; 2023 Jul; 32(13-14):3943-3953. PubMed ID: 36345133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptance of COVID-19 vaccine booster doses among the Adult Population in Ghana: a cross-sectional study using the Health Belief Model.
    Eshun G; Kyei-Arthur F; Abdou MS; Agyekum MW; Sarfo M; Agbenyeavu JK; Addai SA; Adjei JA; Obeng N; Turzin JK; Ghazy RM
    BMC Public Health; 2024 Sep; 24(1):2673. PubMed ID: 39350125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.
    Schwarzinger M; Watson V; Arwidson P; Alla F; Luchini S
    Lancet Public Health; 2021 Apr; 6(4):e210-e221. PubMed ID: 33556325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.